FRANKLIN RESOURCES INC - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 163 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
FRANKLIN RESOURCES INC ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$13,667,957
+3.0%
667,055
-0.1%
0.01%
+16.7%
Q2 2023$13,266,543
+17.1%
667,667
+0.9%
0.01%0.0%
Q1 2023$11,331,752
-12.5%
661,5150.0%0.01%
-14.3%
Q4 2022$12,945,848
+22.6%
661,515
-0.0%
0.01%
+16.7%
Q3 2022$10,562,000
+16.0%
661,761
+0.0%
0.01%
+20.0%
Q2 2022$9,106,000
-57.4%
661,718
-50.9%
0.01%
-44.4%
Q1 2022$21,353,000
-27.4%
1,346,368
-0.1%
0.01%
-18.2%
Q4 2021$29,418,000
-27.0%
1,347,617
-0.0%
0.01%
-26.7%
Q3 2021$40,281,000
-37.0%
1,347,639
-6.7%
0.02%
-37.5%
Q2 2021$63,947,000
-6.0%
1,443,839
-5.9%
0.02%
-14.3%
Q1 2021$68,059,000
-14.4%
1,533,879
+5.8%
0.03%
-17.6%
Q4 2020$79,514,000
+225.3%
1,449,937
+35.6%
0.03%
+183.3%
Q3 2020$24,446,000
+9.8%
1,069,392
+21.6%
0.01%
+9.1%
Q2 2020$22,265,000
+338.4%
879,351
+141.5%
0.01%
+266.7%
Q1 2020$5,079,000
-48.9%
364,100
-16.6%
0.00%
-40.0%
Q4 2019$9,932,000
+85.2%
436,374
-5.2%
0.01%
+66.7%
Q3 2019$5,362,000
-22.3%
460,2740.0%0.00%
-25.0%
Q2 2019$6,904,000
+69.9%
460,274
+98.6%
0.00%
+100.0%
Q1 2019$4,064,000
+18.3%
231,7030.0%0.00%0.0%
Q4 2018$3,434,000
-39.8%
231,7030.0%0.00%
-33.3%
Q3 2018$5,705,000
+25.4%
231,7030.0%0.00%
+50.0%
Q2 2018$4,548,000231,7030.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 665,880$10,627,00011.09%
RTW INVESTMENTS, LP 15,802,802$252,213,0005.82%
Ally Bridge Group (NY) LLC 479,506$7,653,0005.05%
TANG CAPITAL MANAGEMENT LLC 1,265,900$20,204,0002.48%
TIGER MANAGEMENT L.L.C. 279,700$4,464,0001.95%
Prosight Management, LP 200,000$3,192,0001.71%
COWEN AND COMPANY, LLC 999,588$15,953,0001.53%
Boxer Capital, LLC 1,466,051$23,398,0001.32%
Affinity Asset Advisors, LLC 267,794$4,274,0001.19%
HARBOR CAPITAL ADVISORS, INC. 66,410$1,060,0000.97%
View complete list of ROCKET PHARMACEUTICALS INC shareholders